USA Immune Checkpoint Inhibitors Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
Indication (Breast Cancer, Bladder Cancer, Cervical Cancer, Hodgkin Lymphoma, Liver Cancer, Lung Cancer, Kidney Cancer, Solid Cancer, Others), Target (PD-1, PD-L1, CTLA-4, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) United States: the Northeast, the Midwest, the West, and the South
